Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL)

Leukemia

Volumn 16, Issue 6, 2002, Pages 1045-1052

  Faderl, S ^a   Keating, M J ^a   Do, K A ^a   Liang, S Y ^a   Kantarjian, H M ^a   O'Brien, S ^a   Garcia Manero, G ^a   Manshouri, T ^a   Albitar, M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; ATM; Bcl 2; Chronic lymphocytic leukemia; Proliferation; Protein profiling

Indexed keywords

ATM PROTEIN; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CELL PROTEIN; CYCLIN D1; CYCLINE; FAS ANTIGEN; FLT1 LIGAND; PROTEIN BAX; PROTEIN BCL 2; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; APOPTOSIS; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; REVIEW; STATISTICAL ANALYSIS; STATISTICAL MODEL;

EID: 0036272536     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402540     Document Type: Review

References (40)

1. Clinical staging of chronic lymphocytic leukemia
2. Chronic lymphocytic leukemia: Proposals for a revised prognostic staging system
3. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia
4. The serum beta2-microglobulin level is more powerful that stage in predicting response and survival in chronic lymphocytic leukemia
5. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
6. Molecular biology of chronic lymphocytic leukemia
7. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia
8. Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukemia
9. Caspases: The executioners of apoptosis
10. Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells
11. Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia
12. Proliferating cell nuclear antigen (PCNA) expression in chronic lymphocytic leukemia (CLL)
13. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia
14. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia
15. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
16. Proposals for the classification of chronic (mature) B and T lymphoid leukemias
17. Expression profile of MDM-2 proteins in chronic lymphocytic leukemia and their clinical relevance
18. Non-parametric estimation from incomplete observations
19. Clinical trial methodology
20. Regression models and life tables
21. Comparison of the Cox model and the regression tree procedure in analyzing a randomized clinical trial
22. Morphology of sporadic colorectal cancer with DNA replication errors
23. Predictors of hysterectomy: An Australian study
24. Visualizing multivariate models with focus on MARS in an epidemiological case-control study
25. Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma
26. Martingale based residuals for survival models
27. Modern applied statistics with Splus
28. Relative risk trees for censored survival data
29. Tree-based models
30. bcl-2 gene expression in hematopoietic cell differentiation
31. Chronic lymphocytic leukemia in the next decade: Where do we go from here?
32. Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia
33. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: Relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance
34. Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome
35. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia
36. Effect of interleukin-2 on CD95 (Fas/APO-1) expression in fresh chronic lymphocytic leukemia and mantle cell lymphoma cells: Relationship to ex vivo chemoresponse
37. Fas-mediated lysis of chronic lymphocytic leukemia cells: Role of type I versus type II cytokines and autologous fasL-expressing T cells
38. ATM gene deletion in patients with adult acute lymphoblastic leukemia